KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exelixis (EXEL) EPS (Weighted Average and Diluted) (2016 - 2026)

Historic EPS (Weighted Average and Diluted) for Exelixis (EXEL) over the last 15 years, with Q1 2026 value amounting to $0.88.

  • Exelixis' EPS (Weighted Average and Diluted) rose 8333.33% to $0.88 in Q1 2026 from the same period last year, while for Jan 2026 it was $2.77, marking a year-over-year increase of 5649.72%. This contributed to the annual value of $2.78 for FY2026, which is 5795.45% up from last year.
  • Exelixis' EPS (Weighted Average and Diluted) amounted to $0.88 in Q1 2026, which was up 8333.33% from $0.69 recorded in Q4 2025.
  • Exelixis' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.88 during Q1 2026, with a 5-year trough of -$0.09 in Q4 2022.
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was $0.26 (2023), whereas its average is $0.36.
  • Per our database at Business Quant, Exelixis' EPS (Weighted Average and Diluted) plummeted by 13048.6% in 2022 and then surged by 1236021.13% in 2024.
  • Exelixis' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.09 in 2022, then skyrocketed by 400.0% to $0.27 in 2023, then surged by 48.15% to $0.4 in 2024, then surged by 72.5% to $0.69 in 2025, then rose by 27.54% to $0.88 in 2026.
  • Its EPS (Weighted Average and Diluted) was $0.88 in Q1 2026, compared to $0.69 in Q4 2025 and $0.65 in Q3 2025.